References
- Steegers EA, Von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376:631–644.
- Burke SD, Karumanchi SA. Spiral artery remodeling in preeclampsia revisited. Hypertension. 2013;62:1013–1014.
- Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594.
- Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51:970–975.
- Apicella C, Ruano CS, Méhats C, et al. The role of epigenetics in placental development and the etiology of preeclampsia. Int J Molec Sci. 2019;20:2837.
- Waller P, Blann AD. Non-coding RNAs - A primer for the laboratory scientist. Br J Biomed Sci. 2019;76:157–165.
- Landskroner-Eiger S, Moneke I, Sessa WC. miRNAs as modulators of angiogenesis. Cold Spring Harb Perspect Med. 2013;3(2):a006643.
- Bounds KR, Chiasson VL, Pan LJ, et al. MicroRNAs: new players in the pathobiology of preeclampsia. Front Cardiovasc Med. 2017;4:60.
- Mayor-Lynn K, Toloubeydokhti T, Cruz AC, et al. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci. 2011;18:46–56.
- Chen C, Zhang Y, Zhang L, et al. MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Molec Med. 2011;15:14–23.
- Song X, Luo X, Gao Q, et al. Dysregulation of LncRNAs in placenta and pathogenesis of preeclampsia. Curr Drug Targets. 2017;18:1165–1170.
- Zhang Y-H, He K, Shi G. Effects of MicroRNA-499 on the inflammatory damage of endothelial cells during coronary artery disease via the targeting of PDCD4 through the NF-Κβ/TNF-α signaling pathway. Cell Physiol Biochem. 2017;44:110–124.
- Ando H, Asai T, Koide H, et al. Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499. J Control Release. 2014;181:32–39.
- Salimi S, Eskandari F, Rezaei M, et al. The effect of miR-146a rs2910164 and miR-149 rs2292832 polymorphisms on preeclampsia susceptibility. Mol Biol Rep. 2019;46:4529–4536.
- Eskandari F, Rezaei M, Mohammadpour-Gharehbagh A, et al. The association of pri-miRNA- 26a1 rs7372209 polymorphism and Preeclampsia susceptibility. Ann Clin Exp Hypertens. 2019;41:268–273.
- Rokni M, Salimi S, Sohrabi T, et al. Association between miRNA-152 polymorphism and risk of preeclampsia susceptibility. Arch Gynecol Obstet. 2019 Feb;299:475–480.
- Teimoori B, Moradi-shahrebabak M, Razavi M, et al. The effect of GPx-1 rs1050450 and MnSOD rs4880 polymorphisms on PE susceptibility: a case-control study. Mol Biol Rep. 2019;46:6099–6104.
- Bodal VK, Sangwan S, Bal MS, et al. Association between microrna 146a and microrna 196a2 genes polymorphism and breast cancer risk in North Indian women. APJCP. 2017;18:2345.
- Deng S, Wang W, Li X, et al. Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer. World J Surg Oncol. 2015 Oct;13:297. PubMed PMID: 26458899. Pubmed Central PMCID: 4603775.
- Yin Q, Feng W, Shen X, et al. Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis. Biosci Rep. 2018;38:5.
- Luque A, Farwati A, Crovetto F, et al. Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci Rep. 2014;4:4882.
- Chen D-B, Wang W. Human placental microRNAs and preeclampsia. Biol Reprod. 2013;88:1–11.
- Hayder H, O’Brien J, Nadeem U, et al. MicroRNAs: crucial regulators of placental development. Reproduction. 2018;155:R259–R71.
- Pineles BL, Romero R, Montenegro D, et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol. 2007;196:261.e1––6.
- Demirer S, Hocaoglu M, Turgut A, et al. Expression profiles of candidate microRNAs in the peripheral blood leukocytes of patients with early- and late-onset preeclampsia versus normal pregnancies. Pregnancy Hypertens. 2020;19:239–245.
- Lip SV, Boekschoten MV, Hooiveld GJ. Early-onset preeclampsia, plasma microRNAs, and endothelial cell function. Am J Obstet Gynecol. 2020;222:497.e1–497.e12.
- Huang X, Wu L, Zhang G, et al. Elevated microRNA-181a-5p contributes to trophoblast dysfunction and preeclampsia. Reprod Sci. 2019;26:1121–1129.
- Yang X, Meng T. MicroRNA-431 affects trophoblast migration and invasion by targeting ZEB1 in preeclampsia. Gene. 2019;683:225–232.
- Mohseni Z, Spaanderman M, Oben J, et al. Cardiac remodeling and pre-eclampsia: an overview of microRNA expression patterns. Ultrasound Obstet Gynecol. 2018;52:310–317.
- Alipour M, Abtin M, Hosseinzadeh A, et al. Association between miR-146a C> G, miR-149 T> C, miR-196a2 T> C, and miR-499 A> G polymorphisms and susceptibility to idiopathic recurrent pregnancy loss. J Assist Reprod Genet. 2019;36(11):2237–2244.
- Jeon YJ, Choi YS, Rah H. Association study of microRNA polymorphisms with risk of idiopathic recurrent spontaneous abortion in Korean women. Gene. 2012;494:168–173.
- Jeon YJ, Kim SY, Rah H, et al. Association of the mi R-146a C> G, mi R-149T> C, mi R-196a2 T> C, and mi R-499 A> G polymorphisms with risk of spontaneously aborted fetuses. Am J Reproduct Immunol. 2012;68:408–417.